GREEN FRESH BIO (01084) has issued a profit warning, indicating a significant improvement in its financial performance for the first half of the fiscal year.

Based on a preliminary review of available data, including the group's unaudited consolidated management accounts for the six months ended June 30, 2026, the company's board of directors has informed shareholders and potential investors that the group is expected to record a net loss attributable to owners of the company in the range of approximately RMB1 million to RMB4 million for the reporting period.

This represents a substantial narrowing compared to the net loss attributable to owners of the company of RMB12.07 million for the six months ended June 30, 2025. The improved performance is primarily attributed to an increase in sales volume of carrageenan products, driven by the group's competitive pricing strategy, which in turn boosted revenue and gross profit during the reporting period.